peritoneal surface oncology (psogi) modified delphi process (Surface Oncology)
90
Structured Review
Surface Oncology
peritoneal surface oncology (psogi) modified delphi process
Peritoneal Surface Oncology (Psogi) Modified Delphi Process, supplied by Surface Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+delphi+process/peritoneal+surface+oncology/pm39979656-605-30-24
Average 90 stars, based on 1 article reviews
Peritoneal Surface Oncology (Psogi) Modified Delphi Process, supplied by Surface Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/modified+delphi+process/peritoneal+surface+oncology/pm39979656-605-30-24
Average 90 stars, based on 1 article reviews
peritoneal surface oncology (psogi) modified delphi process - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Modification:Article Title: New insights in the pathology of peritoneal surface malignancy Article Snippet: .. Given the plethora of contradictory classifications, a modified Delphi process sponsored by the Article Title: Chirurgisch-onkologische Therapie primärer und sekundärer peritonealer Neoplasien Article Snippet: Cytoreductive surgery and subsequent hyperthermic intraperitoneal chemotherapy (HIPEC) in combination with a multimodal treatment approach is now an established and preferred treatment for patients with low grade malignant peritoneal neoplasms, e.g. pseudomyxoma peritonei.. In recent years the efficacy of this therapy regimen was also demonstrated in mainly retrospective and a few prospective randomized controlled trials for diffuse malignant peritoneal mesothelioma, peritoneal metastases of colorectal cancer and ovarian cancer in selected patients.. This article gives an overview of cytoreductive surgery and HIPEC and illustrates relevant aspects in patient selection regarding the different underlying diseases. Article Title: Current concepts in pseudomyxoma peritonei. Article Snippet: Annales de pathologie (2014) 34, 9—13 Disponible en ligne sur ScienceDirect www.sciencedirect.com ORIGINAL ARTICLE Current concepts in pseudomyxoma peritonei Concepts actuels sur le pseudomyxome péritonéal Norman John Carr Peritoneal Malignancy Centre, Basingstoke and North Hampshire Hospital, Basingstoke, Southampton RG24 9NA, UK Accepted for publication on 17 January 2014 Available online 15 February 2014 KEYWORDS Pseudomyxoma; Summary Each year, about two per million individuals will be diagnosed with pseudomyxoma peritonei, a disease characterised by the intra-abdominal growth of neoplastic mucin-secreting .. The distribution of the disease within the abdomen is not random Grade; cells on peritoneal surfaces Network; Specialized centres but depends on physiological principles.. Most cases derive from neoplasms of the appendix. |